A group of academics is calling on the Canadian government to open a criminal investigation into Purdue Pharma over its marketing of OxyContin, arguing that Canadians have also suffered during the opioid crisis but no manufacturer has been prosecuted and held accountable.

In a letter sent this week to Prime Minister Justin Trudeau, as well as the attorney general and Ministry of Health, the professors maintain the Canadian government should also directly compensate victims of the opioid crisis. This could be accomplished, they contended, with funds that can be generated from new legislation aimed at opioid manufacturers.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy